I don't. Just a gut feel based on prop bids appearing. Plus I know the company wasn't interested in a raising under 20 cents but above is probably a different matter.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%